Development of prediction models for carbapenem-resistant Klebsiella pneumoniae acquisition and prognosis in adult patients

被引:0
|
作者
Yao, Huijuan [1 ]
Yang, Yu [1 ]
Yao, Huimin [2 ]
Bu, Shuhong [1 ]
Li, Lixia [1 ]
Wang, Fang [1 ]
Zhang, Jian [1 ]
Chen, Jihui [1 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Pharm, Shanghai, Peoples R China
[2] Jilin Agr Sci & Technol Univ, Sch Tradit Chinese Med, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
carbapenem-resistant; <italic>Klebsiella pneumoniae</italic>; infection; nomogram; prognosis; RISK-FACTORS; INFECTION;
D O I
10.3389/fphar.2024.1439116
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives To explore the risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae (CRKP) infection and establish nomograms to predict the probability of CRKP infection and mortality in adult patients.Methods Patients infected with KP from August 2019 to April 2021 in a tertiary hospital in Shanghai were enrolled. Risk factors associated with CRKP and 30-day mortality were identified using multivariate logistic regression analysis and Cox regression analysis.Results Overall, 467 patients with KP infection were enrolled, wherein 210 (45.0%) patients were infected with CRKP and 257 (55.0%) patients with carbapenem-susceptible K. pneumoniae (CSKP). Five factors, namely Charlson's Comorbidity Index (CCI) >= 3, the use of central venous catheterization, prior hospitalization during the 3 months before infection, and previous exposure to carbapenems and broad-spectrum beta-lactams, were found to be independently associated with CRKP infection. Based on these parameters, the nomogram showed a better performance as indicated by C-index of 0.94 (95% confidence interval [CI]: 0.92-0.96) and well-fitted calibration curves. CRKP was independently associated with 30-day mortality. Multivariate Cox regression analysis revealed that age >= 65 years, higher CCI scores, higher Sequential Organ Failure Assessment scores, the presence of respiratory failure, albumin levels <= 30 g/L, and non-appropriate treatments in 3 days, were associated with 30-day mortality.Conclusion The predictive nomogram established in this study can facilitate the clinicians to make better clinical decisions when treating patients with KP infection.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Rapid susceptibility profiling of carbapenem-resistant Klebsiella pneumoniae
    Mulroney, K. T.
    Hall, J. M.
    Huang, X.
    Turnbull, E.
    Bzdyl, N. M.
    Chakera, A.
    Naseer, U.
    Corea, E. M.
    Ellington, M. J.
    Hopkins, K. L.
    Wester, A. L.
    Ekelund, O.
    Woodford, N.
    Inglis, T. J. J.
    SCIENTIFIC REPORTS, 2017, 7
  • [42] Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art
    Petrosillo, Nicola
    Giannella, Maddalena
    Lewis, Russell
    Viale, Pierluigi
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (02) : 159 - 177
  • [43] Virulence factors in carbapenem-resistant hypervirulent Klebsiella pneumoniae
    Mendes, Gabriel
    Santos, Maria Leonor
    Ramalho, Joao F.
    Duarte, Aida
    Caneiras, Catia
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [44] Toward our understanding of carbapenem-resistant Klebsiella pneumoniae
    Li, Liqiang
    Qu, Jiuxin
    CHINESE SCIENCE BULLETIN-CHINESE, 2025, 70 (02): : 148 - 150
  • [45] Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
    Wang, Zhe
    Qin, Ran-Ran
    Huang, Lei
    Sun, Li-Ying
    CHINESE MEDICAL JOURNAL, 2018, 131 (01) : 56 - 62
  • [46] Risk Factors for Carbapenem-resistant Klebsiella pneumoniae Infection and Mortality of Klebsiella pneumoniae Infection
    Wang Zhe
    Qin Ran-Ran
    Huang Lei
    Sun Li-Ying
    中华医学杂志英文版, 2018, 131 (01) : 56 - 62
  • [47] Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae
    Borer, Abraham
    Saidel-Odes, Lisa
    Eskira, Seada
    Nativ, Ronit
    Riesenberg, Klaris
    Livshiz-Riven, Ilana
    Schlaeffer, Francisc
    Sherf, Michael
    Peled, Nejama
    AMERICAN JOURNAL OF INFECTION CONTROL, 2012, 40 (05) : 421 - 425
  • [48] Tigecycline-Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae
    Shi, Shiyi
    Xu, Mengxin
    Zhao, Yining
    Feng, Luozhu
    Liu, Qi
    Yao, Zhuocheng
    Sun, Yao
    Zhou, Tieli
    Ye, Jianzhong
    ACS INFECTIOUS DISEASES, 2023, 9 (10): : 1858 - 1866
  • [49] Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult Successful treatment with gentamicin and colistin
    Benenson, Shmuel
    Navon-Venezia, Shiri
    Carmeli, Yehuda
    Adler, Amos
    Strahilevitz, Jacob
    Moses, Allon E.
    Block, Colin
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (05) : E295 - E298
  • [50] Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia
    Lee, Nan-Yao
    Lo, Ching-Lung
    Chen, Po-Lin
    Syue, Ling-Shan
    Li, Chia-Wen
    Li, Ming-Chi
    Ko, Wen-Chien
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (02)